NASDAQ : TXG
10x Genomics, Inc. — Financial statements
Healthcare · Health Information Services · United States
Last price 81.55 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 10.63B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
10x Genomics, Inc. (TXG) reported revenue of 616.91M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 616.91M | 642.82M | 610.78M | 618.73M | 516.41M | 490.49M |
| Cost of Revenue | 184.38M | 198.44M | 196.30M | 209.41M | 120.09M | 74.09M |
| Gross Profit | 432.53M | 444.38M | 414.48M | 409.31M | 396.32M | 416.40M |
| Selling, General & Admin | 291.01M | 310.13M | 343.24M | 343.33M | 295.80M | 257.56M |
| Research & Development | 222.70M | 234.53M | 264.70M | 265.73M | 264.27M | 211.75M |
| Operating Expenses | 513.71M | 544.67M | 607.94M | 609.06M | 560.07M | 469.31M |
| Operating Income | -81.18M | -100.28M | -193.46M | -199.75M | -163.74M | -52.91M |
| Interest Expense | -4.00K | -33.00K | -476.00K | -866.00K | ||
| Interest & Investment Income | 21.91M | 20.05M | 18.93M | 16.89M | 6.65M | 206.00K |
| Currency Exchange Gain (Loss) | -2.30M | 2.50M | -2.10M | 1.20M | 200.00K | -900.00K |
| Other Non Operating Income (Expenses) | -2.65M | -1.47M | 33.00K | -1.49M | -398.00K | 98.00K |
| EBT Excluding Unusual Items | -64.22M | -79.21M | -176.60M | -183.18M | -157.77M | -54.38M |
| Merger & Restructuring Charges | -10.60M | -10.60M | -4.20M | |||
| Asset Writedown | -1.10M | -4.60M | ||||
| Legal Settlements | 3.40M | 49.90M | 660.00K | |||
| Other Unusual Items | -3.47M | |||||
| Pretax Income | -74.89M | -39.91M | -177.70M | -248.76M | -161.97M | -53.72M |
| Income Tax Expense | 235.00K | 3.64M | 4.93M | 6.34M | 4.03M | 4.51M |
| Net Income | -75.12M | -43.54M | -182.63M | -255.10M | -166.00M | -58.22M |
| Net Income to Common | -75.12M | -43.54M | -182.63M | -255.10M | -166.00M | -58.22M |
| Shares Outstanding (Basic) | 127.68M | 124.75M | 120.45M | 117.17M | 113.86M | 110.35M |
| Shares Outstanding (Diluted) | 127.68M | 124.75M | 120.45M | 117.17M | 113.86M | 110.35M |
| EPS (Basic) | -0.59 | -0.35 | -1.52 | -2.18 | -1.46 | -0.53 |
| EPS (Diluted) | -0.59 | -0.35 | -1.52 | -2.18 | -1.46 | -0.53 |
| Free Cash Flow | 121.44M | 130.12M | -5.73M | -63.80M | -165.27M | -122.65M |
| Free Cash Flow Per Share | 0.95 | 1.04 | -0.05 | -0.55 | -1.45 | -1.11 |
| Gross Margin | 70.11% | 69.13% | 67.86% | 66.15% | 76.75% | 84.89% |
| Operating Margin | -13.16% | -15.60% | -31.67% | -32.28% | -31.71% | -10.79% |
| Profit Margin | -12.18% | -6.77% | -29.90% | -41.23% | -32.15% | -11.87% |
| Free Cash Flow Margin | 19.68% | 20.24% | -0.94% | -10.31% | -32.00% | -25.01% |
| EBITDA | -41.20M | -64.09M | -157.58M | -164.24M | -138.38M | -31.80M |
| EBITDA Margin | -6.68% | -9.97% | -25.80% | -26.54% | -26.80% | -6.48% |
| D&A For EBITDA | 39.98M | 36.20M | 35.88M | 35.51M | 25.37M | 21.12M |
| EBIT | -81.18M | -100.28M | -193.46M | -199.75M | -163.74M | -52.91M |
| EBIT Margin | -13.16% | -15.60% | -31.67% | -32.28% | -31.71% | -10.79% |
| Revenue as Reported | 616.91M | 642.82M | 610.78M | 618.73M | ||
| Advertising Expenses | 2.50M | 3.90M | 3.30M | 3.70M | 4.70M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 502.51M | 473.97M | 344.07M | 359.28M | 219.75M | 587.45M |
| Short-Term Investments | 49.52M | 49.44M | 49.34M | 29.41M | 210.24M | |
| Cash & Short-Term Investments | 552.03M | 523.41M | 393.40M | 388.69M | 429.98M | 587.45M |
| Accounts Receivable | 47.55M | 47.01M | 87.86M | 114.83M | 104.21M | 85.25M |
| Other Receivables | 3.08M | 35.48M | 606.00K | |||
| Receivables | 50.63M | 82.49M | 88.47M | 114.83M | 104.21M | 85.25M |
| Inventory | 52.62M | 56.34M | 83.11M | 73.71M | 81.63M | 59.97M |
| Prepaid Expenses | 19.39M | 22.21M | 19.41M | 18.79M | 16.58M | 13.90M |
| Restricted Cash | 2.63M | 1.03M | ||||
| Total Current Assets | 674.67M | 684.45M | 584.39M | 596.02M | 635.03M | 747.59M |
| Property, Plant & Equipment | 272.01M | 287.16M | 309.94M | 344.93M | 359.21M | 230.41M |
| Goodwill | 6.92M | 4.51M | 4.51M | 4.51M | 4.51M | 4.51M |
| Other Intangible Assets | 61.16M | 62.33M | 15.67M | 16.62M | 22.86M | 25.40M |
| Other Long-Term Assets | 15.31M | 2.91M | 4.13M | 3.06M | 7.37M | 10.92M |
| Total Assets | 1.03B | 1.04B | 918.64M | 965.14M | 1.03B | 1.02B |
| Accounts Payable | 20.69M | 12.73M | 12.91M | 15.74M | 21.60M | 17.35M |
| Accrued Expenses | 34.59M | 51.89M | 52.07M | 45.98M | 51.90M | 53.27M |
| Current Portion of Leases | 12.02M | 10.98M | 9.29M | 11.52M | 9.04M | 5.13M |
| Current Income Taxes Payable | 6.95M | 7.22M | 4.94M | 5.05M | 4.08M | 4.62M |
| Current Unearned Revenue | 23.61M | 23.90M | 20.66M | 13.15M | 7.87M | 5.34M |
| Other Current Liabilities | 20.66M | 46.73M | 17.77M | 35.73M | 36.48M | 24.64M |
| Total Current Liabilities | 118.51M | 153.45M | 117.63M | 127.16M | 130.96M | 110.36M |
| Long-Term Leases | 66.78M | 73.38M | 73.33M | 83.85M | 86.14M | 76.85M |
| Long-Term Unearned Revenue | 9.68M | 10.50M | 12.51M | 8.81M | 3.17M | |
| Other Long-Term Liabilities | 9.55M | 7.71M | 5.03M | 4.28M | 2.98M | 14.05M |
| Total Liabilities | 204.52M | 245.04M | 208.50M | 224.10M | 223.24M | 201.26M |
| Common Stock | 2.00K | 2.00K | 2.00K | 2.00K | 2.00K | 2.00K |
| Additional Paid-In Capital | 2.37B | 2.31B | 2.18B | 2.03B | 1.84B | 1.68B |
| Retained Earnings | -1.54B | -1.51B | -1.47B | -1.28B | -1.03B | -863.32M |
| Comprehensive Income & Other | 77.00K | 225.00K | -493.00K | -429.00K | -4.33M | 22.00K |
| Total Common Equity | 825.55M | 796.33M | 710.13M | 741.04M | 805.74M | 817.57M |
| Shareholders' Equity | 825.55M | 796.33M | 710.13M | 741.04M | 805.74M | 817.57M |
| Total Liabilities & Equity | 1.03B | 1.04B | 918.64M | 965.14M | 1.03B | 1.02B |
| Total Debt | 78.80M | 84.36M | 82.61M | 95.37M | 95.18M | 81.98M |
| Net Cash (Debt) | 473.24M | 439.05M | 310.79M | 293.32M | 334.81M | 505.47M |
| Net Cash Per Share | 3.71 | 3.52 | 2.58 | 2.50 | 2.94 | 4.58 |
| Filing Date Shares Outstanding | 130.29M | 127.75M | 122.30M | 119.17M | 115.36M | 112.84M |
| Total Common Shares Outstanding | 130.28M | 127.69M | 122.29M | 119.10M | 115.20M | 112.51M |
| Working Capital | 556.16M | 531.00M | 466.75M | 468.86M | 504.08M | 637.23M |
| Book Value Per Share | 6.34 | 6.24 | 5.81 | 6.22 | 6.99 | 7.27 |
| Tangible Book Value | 757.47M | 729.49M | 689.95M | 719.92M | 778.37M | 787.66M |
| Tangible Book Value Per Share | 5.81 | 5.71 | 5.64 | 6.04 | 6.76 | 7.00 |
| Land | 36.77M | 36.77M | 36.77M | 36.77M | 36.78M | 36.10M |
| Buildings | 147.61M | 147.49M | 147.09M | 146.04M | ||
| Machinery | 106.24M | 103.26M | 97.04M | 96.60M | 76.86M | 62.69M |
| Construction In Progress | 2.06M | 2.93M | 5.15M | 7.25M | 153.00M | 52.19M |
| Leasehold Improvements | 90.40M | 89.72M | 89.57M | 96.41M | 91.52M | 67.53M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -75.12M | -43.54M | -182.63M | -255.10M | -166.00M | -58.22M |
| Depreciation & Amortization | 47.60M | 43.82M | 43.71M | 43.62M | 33.01M | 28.25M |
| Asset Writedown & Restructuring Costs | 700.00K | 814.00K | 3.05M | 9.85M | ||
| Loss (Gain) From Sale of Investments | 3.00K | 1.72M | ||||
| Stock-Based Compensation | 98.74M | 109.12M | 140.75M | 166.95M | 136.85M | 95.96M |
| Other Operating Activities | 3.59M | 907.00K | 523.00K | 427.00K | 1.96M | 79.00K |
| Change in Accounts Receivable | 2.86M | 41.31M | 26.95M | -10.61M | -18.95M | -34.04M |
| Change in Inventory | 18.57M | 27.95M | -9.78M | 7.87M | -21.19M | -30.13M |
| Change in Accounts Payable | 2.46M | -2.13M | -3.35M | -6.02M | 5.86M | 11.08M |
| Change in Unearned Revenue | -305.00K | 746.00K | 11.21M | 10.93M | 3.35M | 1.53M |
| Change in Other Net Operating Assets | 27.99M | -42.95M | -23.77M | 15.17M | -8.48M | -35.89M |
| Operating Cash Flow | 127.08M | 136.05M | 6.66M | -15.20M | -33.61M | -21.37M |
| Capital Expenditures | -5.65M | -5.93M | -12.39M | -48.60M | -131.66M | -101.28M |
| Cash Acquisitions | -15.37M | -9.27M | -4.00M | -5.45M | ||
| Sale (Purchase) of Intangibles | -1.00M | -923.00K | ||||
| Investment in Securities | 1.37M | 1.76M | -19.24M | 183.02M | -215.23M | |
| Investing Cash Flow | -19.65M | -13.44M | -32.63M | 133.49M | -350.89M | -106.73M |
| Long-Term Debt Repaid | -5.81M | -5.41M | -5.03M | |||
| Total Debt Repaid | -5.81M | -5.41M | -5.03M | |||
| Net Debt Issued (Repaid) | -5.81M | -5.41M | -5.03M | |||
| Issuance of Common Stock | 6.15M | 6.80M | 10.91M | 19.48M | 21.23M | 40.33M |
| Financing Cash Flow | -2.54M | 6.80M | 10.91M | 13.67M | 15.82M | 35.30M |
| Foreign Exchange Rate Adjustments | -91.00K | 484.00K | -164.00K | -33.00K | -44.00K | 234.00K |
| Net Cash Flow | 104.80M | 129.90M | -15.22M | 131.93M | -368.72M | -92.57M |
| Free Cash Flow | 121.44M | 130.12M | -5.73M | -63.80M | -165.27M | -122.65M |
| Free Cash Flow Margin | 19.68% | 20.24% | -0.94% | -10.31% | -32.00% | -25.01% |
| Free Cash Flow Per Share | 0.95 | 1.04 | -0.05 | -0.55 | -1.45 | -1.11 |
| Levered Free Cash Flow | 179.66M | 148.39M | 59.20M | 27.63M | -92.66M | -67.02M |
| Unlevered Free Cash Flow | 179.66M | 148.39M | 59.20M | 27.65M | -92.36M | -66.48M |
| Cash Interest Paid | 436.00K | 841.00K | 1.22M | |||
| Cash Income Tax Paid | 2.02M | 2.39M | 5.64M | 4.93M | 3.92M | 8.66M |
| Change in Working Capital | 51.58M | 24.94M | 1.25M | 17.34M | -39.42M | -87.44M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 8.47B | 2.06B | 1.74B | 6.61B | 4.17B | 16.64B |
| Enterprise Value | 8.00B | 1.67B | 1.43B | 6.36B | 3.81B | 16.12B |
| Last Close Price | 70.11 | 16.31 | 14.36 | 55.96 | 36.44 | 148.96 |
| PS Ratio | 14.67 | 3.21 | 2.85 | 10.69 | 8.08 | 33.92 |
| PB Ratio | 11.06 | 2.59 | 2.45 | 8.93 | 5.18 | 20.35 |
| P/TBV Ratio | 11.95 | 2.83 | 2.52 | 9.19 | 5.36 | 21.13 |
| P/FCF Ratio | 74.54 | 15.86 | ||||
| P/OCF Ratio | 71.22 | 15.17 | 260.86 | |||
| EV/Sales Ratio | 13.90 | 2.60 | 2.33 | 10.27 | 7.39 | 32.86 |
| EV/FCF Ratio | 70.64 | 12.83 | ||||
| Debt / Equity Ratio | 0.10 | 0.11 | 0.12 | 0.13 | 0.12 | 0.10 |
| Debt / FCF Ratio | 0.65 | 0.65 | ||||
| Net Debt / Equity Ratio | -0.57 | -0.55 | -0.44 | -0.40 | -0.42 | -0.62 |
| Net Debt / EBITDA Ratio | 11.49 | 6.85 | 1.97 | 1.79 | 2.42 | 15.90 |
| Net Debt / FCF Ratio | -3.90 | -3.37 | 54.25 | 4.60 | 2.03 | 4.12 |
| Asset Turnover | 0.61 | 0.66 | 0.65 | 0.62 | 0.50 | 0.50 |
| Inventory Turnover | 3.03 | 2.85 | 2.50 | 2.70 | 1.70 | 1.65 |
| Quick Ratio | 5.08 | 3.95 | 4.10 | 3.96 | 4.08 | 6.10 |
| Current Ratio | 5.69 | 4.46 | 4.97 | 4.69 | 4.85 | 6.77 |
| Return on Equity (ROE) | -9.40% | -5.78% | -25.17% | -32.98% | -20.45% | -7.48% |
| Return on Assets (ROA) | -5.05% | -6.40% | -12.84% | -12.52% | -9.99% | -3.40% |
| Return on Capital Employed (ROCE) | -8.90% | -11.30% | -24.20% | -23.80% | -18.20% | -5.80% |
| Earnings Yield | -0.90% | -2.11% | -10.51% | -3.86% | -3.98% | -0.35% |
| FCF Yield | 1.34% | 6.30% | -0.33% | -0.96% | -3.96% | -0.74% |
| Buyback Yield / Dilution | -4.39% | -3.57% | -2.80% | -2.90% | -3.18% | -9.09% |